What is the conversion from oral Metoprolol (beta blocker) to intravenous (IV) Metoprolol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2025 • View editorial policy

From the Guidelines

When converting from oral metoprolol to intravenous (IV) metoprolol, the recommended approach is to administer IV metoprolol in 5-mg increments by slow intravenous administration (5 mg over 1 to 2 min), repeated every 5 min for a total initial dose of 15 mg, as this method is supported by the 2013 ACCF/AHA guidelines 1. The choice of beta blocker for an individual patient is based primarily on pharmacokinetic and side effect criteria, as well as on physician familiarity.

  • Key considerations for metoprolol conversion include:
    • Intravenous metoprolol may be given in 5-mg increments by slow intravenous administration (5 mg over 1 to 2 min), repeated every 5 min for a total initial dose of 15 mg.
    • In patients who tolerate the total 15-mg IV dose, oral therapy can be initiated 15 min after the last intravenous dose at 25 to 50 mg every 6 h for 48 h.
    • Thereafter, patients should receive a maintenance dose of up to 100 mg twice daily. The target resting heart rate is 50 to 60 beats per minute unless a limiting side effect is reached.
  • Monitoring during intravenous beta-blocker therapy should include:
    • Frequent checks of heart rate and blood pressure
    • Continuous ECG monitoring
    • Auscultation for rales and bronchospasm It's essential to note that beta blockade also may be started orally, in smaller initial doses if appropriate, within the first 24 h, in cases in which a specific clinical indication for intravenous initiation is absent or the safety of aggressive early beta blockade is a concern, as stated in the 2013 ACCF/AHA guidelines 1.

From the FDA Drug Label

In patients who tolerate the full intravenous dose (15 mg), initiate metoprolol tartrate tablets, 50 mg every 6 hours, 15 minutes after the last intravenous dose and continued for 48 hours. Start patients who appear not to tolerate the full intravenous on metoprolol tartrate tablets either 25 mg or 50 mg every 6 hours (depending on the degree of intolerance) 15 minutes after the last intravenous dose or as soon as their clinical condition allows.

The conversion from intravenous (IV) to oral metoprolol is as follows:

  • Patients who tolerate the full IV dose of 15 mg can be started on 50 mg orally every 6 hours.
  • Patients who do not tolerate the full IV dose can be started on 25 mg or 50 mg orally every 6 hours, depending on the degree of intolerance. 2

From the Research

Metoprolol Oral to IV Conversion

  • The provided studies do not directly address the conversion of metoprolol from oral to IV administration.
  • However, studies 3 and 4 discuss the use of metoprolol in various clinical settings, including hypertension and coronary CT angiography.
  • Study 3 mentions that metoprolol is generally well tolerated and its beta 1-selectivity may facilitate its administration to certain patients.
  • Studies 4 and 5 compare the efficacy of esmolol and metoprolol in achieving target heart rates during coronary CT angiography, but do not provide information on oral to IV conversion of metoprolol.

Efficacy of Esmolol and Metoprolol

  • Studies 4 and 5 demonstrate that both esmolol and metoprolol are effective in achieving target heart rates during coronary CT angiography.
  • Esmolol is shown to have a faster onset and shorter duration of action compared to metoprolol, with less profound and shorter duration of reduction in systolic blood pressure 5.
  • Study 6 compares the efficacy of esmolol and nicardipine in hypertensive acute ischemic stroke patients, but does not provide information on metoprolol oral to IV conversion.

Clinical Considerations

  • When converting metoprolol from oral to IV administration, clinicians should consider the patient's individual needs and clinical status.
  • The provided studies do not offer specific guidance on the conversion ratio or dosing regimen for metoprolol oral to IV administration.
  • Clinicians should consult relevant clinical guidelines and pharmacological resources to inform their decision-making regarding metoprolol oral to IV conversion 3, 4, 5.

Related Questions

What is the clinical significance of a normal myocardial perfusion study with Lexiscan (regadenoson) and a normal ejection fraction (EF) of 67% with a hypokinetic mid inferolateral segment on echocardiogram?
What is the next step for a 73-year-old male on metoprolol (beta blocker) for hypertension (HTN) with persistent elevated blood pressure (hypertension) in the 150's over 90's?
What are the consequences of administering Lopressor (metoprolol) to a patient already on Levothyroxine (levothyroid, T4) therapy?
What is the best next step for a healthy 32-year-old woman with near daily episodes of palpitations, occasional chest pain, and normal diagnostic test results, including electrocardiogram (EKG), complete blood count (CBC), metabolic panel, and thyroid-stimulating hormone (TSH) levels?
What is the recommended cardiac management for an 18-year-old male patient with confirmed myocarditis, currently off all medications, who was previously treated with indomethacin (nonsteroidal anti-inflammatory drug), colchicine, and metoprolol (beta blocker)?
What is the most common complication of a gastric (peptic) ulcer?
What is the next step in managing a patient with Gastroesophageal Reflux Disease (GERD) who is not responding to Proton Pump Inhibitors (PPI)?
How to treat a female patient with Gastroesophageal Reflux Disease (GERD) who experiences symptoms during prayer time, with an upper gastrointestinal endoscopy (OGD) showing a hiatal hernia above the level of the crura?
What is the most common cause of intestinal obstruction in pediatrics, specifically between Peyer's patches and intussusception?
What is the best treatment for a common carotid artery aneurysm with occlusion of the distal iliac or femoral artery and 70% thrombosis?
What is the oral (po) to intravenous (iv) conversion ratio for Metoprolol (Lopressor)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.